German mRNA company CureVac AG said founder and Chairman Ingmar Hoerr is replacing Daniel Menichella as CEO. Menichella joined the company as CBO as well as CEO of CureVac’s U.S. subsidiary in January 2017, becoming...

A congressional hearing Wednesday on safeguarding pharmaceutical supply chains will focus on concerns that reliance on Chinese APIs threatens U.S. national security and creates health risks for American patients. The House Energy and Commerce Committee’s...

Following a spate of resignations this summer, MiMedx Group Inc. (NASDAQ:MDXG) announced three executive promotions. SVP of Strategic Initiatives Mark Landy was promoted to EVP and chief strategy officer. VP of Medical Affairs David Mason...

Flex Pharma Inc. (NASDAQ:FLKS) said it is cutting headcount by about 60% after discovering its sole clinical program, FLX-787, will require additional work that stretch beyond the biotech's current means. Flex said it will evaluate...

Flex Pharma Inc. (NASDAQ:FLKS) plummeted $3.14 (75%) to $1.04 on Wednesday when the company said it is cutting headcount by about 60% after discovering its sole clinical program, FLX-787, will require additional work that stretch...

Oral therapies developer Chiasma Inc. (Jerusalem, Israel) named Mark Leuchtenberger president and CEO. Leuchtenberger was president and CEO of Acusphere Inc. (Pink:ACUS). Leuchtenberger succeeds Roni Mamluk, whom Chiasma named chief development officer. mRNA technology company...

With its first royalty fund fully deployed and returning cash, OrbiMed Advisors closed a second royalty fund that is 50% larger and recruited new LPs at research and healthcare institutions that could also help source...

Different mindsets, motives and mandates have blocked the progress of companies and academics in forming deals to move discoveries from academia to industry. The solution is a balancing act that engages scientists in the partnerships,...

Acorda Therapeutics Inc. (NASDAQ:ACOR), Hawthorne, N.Y. Business: Neurology, Musculoskeletal, Autoimmune Hired: Enrique Carrazana as CMO, formerly director of the epilepsy center of excellence at the Miami Veterans' Administration Hospital and an associate professor of neurology...

A deal with Eli Lilly (NYSE:LLY) for exclusive U.S. rights to commercialize tadalafil for pulmonary arterial hypertension last week couldn't prevent United Therapeutics (NASDAQ:UTHR) from getting hosed after its oral treprostinil missed the primary endpoint...